Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China.
Cancer Res. 2017 Nov 1;77(21):5831-5845. doi: 10.1158/0008-5472.CAN-17-0579. Epub 2017 Sep 13.
Downregulation of tumor suppressor signaling plays an important role in the pathogenesis of hepatocellular carcinoma (HCC). Here, we report that downregulation of the angiopoietin-like protein is associated with vascular invasion, tumor thrombus, metastasis, and poor prognosis in HCC. Ectopic expression of in HCC cells effectively decreased their and tumorigenicity, cell motility, and angiogenesis. shRNA-mediated depletion of exerted opposing effects. promoted apoptosis via inhibition of the STAT3/Bcl-2-mediated antiapoptotic pathway and decreased cell migration and invasion via downregulation of transcription factors SNAIL and SLUG. Furthermore, inhibited angiogenesis by attenuating ERK and AKT signaling and interacted with integrin α1β1 receptor to suppress the downstream FAK/Src-JAK-STAT3 signaling pathway. Taken together, these results suggest as a prognostic biomarker and novel therapeutic agent in HCC. .
肿瘤抑制信号的下调在肝细胞癌(HCC)的发病机制中起着重要作用。在这里,我们报告血管生成素样蛋白的下调与 HCC 中的血管侵犯、肿瘤血栓、转移和不良预后相关。在 HCC 细胞中外源性表达 可有效降低其 和 的肿瘤形成能力、细胞迁移和血管生成能力。shRNA 介导的 耗竭则产生相反的效果。 通过抑制 STAT3/Bcl-2 介导的抗凋亡途径促进细胞凋亡,并通过下调转录因子 SNAIL 和 SLUG 减少细胞迁移和侵袭。此外, 通过抑制 ERK 和 AKT 信号通路来抑制血管生成,并与整合素 α1β1 受体相互作用来抑制下游 FAK/Src-JAK-STAT3 信号通路。综上所述,这些结果表明 是 HCC 的一个预后生物标志物和新型治疗剂。